Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT
Status:
Terminated
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
To compare the livebirth rate of women with recurrent pregnancy loss and autoantibodies
randomized to either low molecular weight heparin plus aspirin versus aspirin alone.
Phase:
N/A
Details
Lead Sponsor:
Mount Sinai Hospital, Canada
Collaborators:
Canadian Institutes of Health Research (CIHR) Pfizer